by
Allison Schrager
Most people are probably thinking about retirement all wrong, and probably better off than they think.
by
Paul Lofties, Catherine McBreen
A shocking number of affluent investors are actively looking to work with new advisors or are open to the idea of switching.
by
Joellen Meckley
Here are ways you can empower clients to navigate the intricate landscape of caregiving with confidence and resilience.
by
Alyson Dorosky
Here are a few ways the agency bestows financial security to its beneficiaries and their survivors and dependents.
by
Allison Schrager
Cheap mortgages over the last decade have enabled millions of millennials to buy homes, but it's harder for younger buyers.
by
Kathryn Anne Edwards
If you think of them as workers instead of consumers, it's easy to understand their dissatisfaction.
by
Jack Sharry
To earn the “Amazon” moniker, firms need to integrate all of the functions of a comprehensive advice platform.
by Commonwealth Financial Network
To help you approach these conversations, and help your clients be strategic in their philanthropy efforts, we've created a guide to HNW charitable planning.
by
Rona Guymon
Here are some common investor misconceptions that may be turning your clients away from annuities.
by
Daniel Crosby
Advisors can use behavioral finance to help clients capture higher returns on their investments.
by
Justin Fox
The potential role of tax revenue in closing federal budget deficits deserves more attention.
by
Bryce Sanders
Becoming a regular at the “see and be seen” restaurant is a stepping stone to becoming part of the HNW community.
by
Ed Slott
There's a lot of confusion on who will be subject to required minimum distributions before year end.
by
Nick Graham
A number of questions have emerged about how AI will affect financial services.
by
Allison Schrager
A Supreme Court case about unrealized capital gains has implications for Biden's proposed tax on the very wealthy.
by
Mark Hurley
Successful advisory firms will have to do these 10 things to thrive.
by
Lisa Jarvis
The science around designing and testing smart-bomb chemotherapy has coalesced.
